[
  {
    "criterion": "Provides a clear summary of statin therapy guidelines for CKD stage 4",
    "axis": "completeness",
    "point": 9
  },
  {
    "criterion": "Incorrectly states that statin therapy is not recommended for CKD stage 4",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "Fails to consider the patient's cardiovascular risk profile when recommending statin therapy",
    "axis": "context_awareness",
    "point": -5
  },
  {
    "criterion": "Response is unclear and lacks specific guidance on statin therapy for CKD stage 4",
    "axis": "communication_quality",
    "point": -3
  },
  {
    "criterion": "Advises against using statins for CKD stage 4 without providing alternative treatment options",
    "axis": "instruction_following",
    "point": -2
  },
  {
    "criterion": "Mentions the importance of monitoring kidney function and potential side effects when starting statin therapy for CKD stage 4",
    "axis": "completeness",
    "point": 7
  },
  {
    "criterion": "Correctly differentiates between ACC/AHA and KDIGO guidelines for statin therapy in CKD stage 4",
    "axis": "accuracy",
    "point": 6
  },
  {
    "criterion": "Provides a nuanced discussion of the potential benefits and risks of statin therapy for CKD stage 4",
    "axis": "communication_quality",
    "point": 5
  },
  {
    "criterion": "Does not recommend statin therapy for CKD stage 4 without a clear medical indication",
    "axis": "context_awareness",
    "point": 4
  },
  {
    "criterion": "Incorrectly states that fibrate therapy is recommended for CKD stage 4",
    "axis": "accuracy",
    "point": -9
  }
]